Niagen Bioscience Inc (NAGE)

Cost of Revenue

$10.47M

Quarterly · Period ending: · USD

NAGE logo

NAGE Cost of Revenue

Latest reported$10.47M
NAGE Quarterly Cost of Revenue ($0.00 → $10.47M)
High-resolution chart · PNG

NAGE cost of revenue history

Quarterly · USD. Dates are reporting period ends; fiscal years can differ from calendar years.

Niagen Bioscience Inc Cost of Revenue — Quarterly (USD)
Period endingCost of Revenue (USD)
10,471,000
11,498,000
12,135,000
12,058,000
10,891,000
11,150,000
10,928,000
9,340,000
9,046,000
8,697,000
8,259,000
7,526,000
7,967,000
9,038,000
8,980,000
6,856,000
6,690,000
6,727,000
6,891,000
6,730,000
6,889,000
5,449,000
6,024,000
5,726,000
6,199,000
6,034,000
5,624,000
5,304,000
4,847,000
4,747,000
4,356,000
3,759,000
3,957,000
3,430,000
3,695,837
3,169,000
2,109,000
1,750,000
3,342,316
2,074,325
4,702,132
3,880,526
2,763,418
3,805,679
3,630,688
3,333,347
2,824,232
2,616,764
2,457,388
2,089,130
1,651,925
1,968,020
1,746,158
1,661,726
2,661,930
2,377,991
1,905,916
2,389,220
1,403,783
1,361,101
1,357,058
1,518,850
1,184,108
1,059,626
1,258,172
1,119,619
939,267
953,043
865,071
979,054
899,783
881,839
832,905
0
0
0
0
Data is provided for informational purposes only and does not constitute investment advice. Past performance is not indicative of future results.